Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
119.33-1.97 (-1.62%)
At close: 04:00PM EDT
119.44 +0.11 (+0.09%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 24.52B
Enterprise value 30.01B
Trailing P/E 24.45
Forward P/E 14.86
PEG ratio (5-yr expected) 4.49
Price/sales (ttm)3.38
Price/book (mrq)1.96
Enterprise value/revenue 4.06
Enterprise value/EBITDA 13.52

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-13.48%
S&P500 52-week change 321.23%
52-week high 3149.25
52-week low 3102.00
50-day moving average 3126.27
200-day moving average 3121.37

Share statistics

Avg vol (3-month) 31.44M
Avg vol (10-day) 31.17M
Shares outstanding 5205.46M
Implied shares outstanding 6205.46M
Float 8204.56M
% held by insiders 10.13%
% held by institutions 190.95%
Shares short (28 Mar 2024) 44.73M
Short ratio (28 Mar 2024) 43.67
Short % of float (28 Mar 2024) 42.61%
Short % of shares outstanding (28 Mar 2024) 42.30%
Shares short (prior month 29 Feb 2024) 44.9M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.80%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.79%
5-year average dividend yield 40.74
Payout ratio 419.67%
Dividend date 330 Apr 2024
Ex-dividend date 427 Mar 2024
Last split factor 2103:100
Last split date 301 Mar 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.85%
Operating margin (ttm)23.70%

Management effectiveness

Return on assets (ttm)4.40%
Return on equity (ttm)8.36%

Income statement

Revenue (ttm)7.39B
Revenue per share (ttm)35.43
Quarterly revenue growth (yoy)6.30%
Gross profit (ttm)N/A
EBITDA 2.45B
Net income avi to common (ttm)1.02B
Diluted EPS (ttm)4.88
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)415.8M
Total cash per share (mrq)2.03
Total debt (mrq)6.21B
Total debt/equity (mrq)49.71%
Current ratio (mrq)1.61
Book value per share (mrq)60.70

Cash flow statement

Operating cash flow (ttm)1.58B
Levered free cash flow (ttm)1.14B